<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>POTASSIUM CHLORIDE IN DEXTROSE- dextrose and potassium chloride solution </strong><br>B. Braun Medical Inc.<br></p></div>
<h1>Potassium Chloride in 5% Dextrose Injections USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_97c2aae7-8e45-4792-a1b3-3c8675d56557"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">(See chart below for quantitative information.)</p>
<p>Potassium Chloride in 5% Dextrose Injections USP are sterile, nonpyrogenic and contain no bacteriostatic or antimicrobial agents. These products are intended for intravenous administration.</p>
<p>The formulas of the active ingredients are:</p>
<table>
<col>
<col>
<col>
<thead><tr class="First Last">
<th align="center">Ingredients </th>
<th align="center">Molecular Formula </th>
<th align="center">Molecular Weight</th>
</tr></thead>
<tbody>
<tr class="First">
<td> Potassium Chloride USP</td>
<td align="center"> KCl</td>
<td align="center">   74.55</td>
</tr>
<tr>
<td>   </td>
<td align="center"> </td>
<td align="center"> </td>
</tr>
<tr class="Last">
<td> Hydrous Dextrose USP</td>
<td align="center"> <img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&amp;name=potassium-chloride-in-dextrose-in-excel-1.jpg">
</td>
<td align="center"> 198.17</td>
</tr>
</tbody>
</table>
<table>
<col>
<col>
<col>
<col>
<col>
<col>
<col>
<col>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" colspan="3" valign="top"> <span class="Bold">Composition – Each 100 mL contains:</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" colspan="2" rowspan="2" valign="top"> <span class="Bold">Concentration of Electrolytes <br>(mEq/liter)</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" rowspan="3" valign="bottom">
<span class="Bold">Calories per liter</span> </td>
<td class="Botrule Lrule Rrule Toprule" align="center" rowspan="3" valign="bottom">
<span class="Bold">Calculated Osmolarity<br>mOsmol/liter</span> </td>
<td class="Botrule Lrule Rrule Toprule" align="center" rowspan="3" valign="bottom"> <span class="Bold">pH</span>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" rowspan="2" valign="top"> <span class="Bold">Solution</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" rowspan="2" valign="top">
<span class="Bold">Hydrous Dextrose USP</span> </td>
<td class="Botrule Lrule Rrule Toprule" align="center" rowspan="2" valign="top"><span class="Bold">Potassium Chloride USP</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><span class="Bold"> Potassium</span></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"> <span class="Bold">Chloride</span>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top"> 0.15% Potassium Chloride in 5% Dextrose Injection USP<br>(20 mEq K<span class="Sup">+</span>/liter)</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 5 g</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 0.15 g</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 20</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 20</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 170</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 295</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 4.3 (3.5–6.5)</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top"> 0.30% Potassium Chloride in 5% Dextrose Injection USP<br>(40 mEq K<span class="Sup">+</span>/liter)</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 5 g</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 0.3 g</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 40</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 40</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 170</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 330</td>
<td class="Botrule Lrule Rrule Toprule" align="center"> 4.3 (3.5–6.5)</td>
</tr>
<tr class="Last"><td class="Botrule Lrule Rrule Toprule" colspan="8" valign="top"> Water for Injection USP qs</td></tr>
</tbody>
</table>
<p>The EXCEL® Container is Latex-free, PVC-free, and DEHP-free.</p>
<p>The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary. </p>
<p>Addition of medication should be accomplished using complete aseptic technique.</p>
<p>The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication addition site. Refer to the Directions for Use of the container.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="LINK_fb17c5d7-fadd-47d0-93a9-16452c020c3b"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">These intravenous solutions provide electrolytes and calories, and are a source of water for hydration. All are capable of inducing <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span> depending on the clinical condition of the patient. </p>
<p>Potassium, the principal cation of intracellular fluid, participates in carbohydrate utilization and protein synthesis, and is critical in the regulation of nerve conduction and muscle contraction, particularly in the heart.</p>
<p>Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration.</p>
<p>Dextrose provides a source of calories. Dextrose is readily metabolized, may decrease losses of body protein and nitrogen, promotes glycogen deposition and decreases or prevents <span class="product-label-link" type="condition" conceptid="4101761" conceptname="Ketosis">ketosis</span> if sufficient doses are provided.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_1c36698c-411a-4a88-b7c5-2d47524ebc8f"></a><a name="section-2.1"></a><p></p>
<h2></h2>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="LINK_9661bd9f-458c-42d0-994f-c78f01aea5b2"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">These intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories, and water for hydration.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="LINK_a9684f07-105b-418a-8cb8-fb4003e2a5b8"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">These solutions are contraindicated where the administration of potassium or chloride could be clinically detrimental.</p>
<p>Solutions containing dextrose may be contraindicated in patients with <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to corn products.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_65a68f50-87eb-4ba1-91b3-1c6ef7c2a01e"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, <span class="product-label-link" type="condition" conceptid="4266976" conceptname="Overhydration">overhydration</span>, congested states or <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>. The risk of dilutional states is inversely proportional to the electrolyte concentration. The risk of solute overload causing congested states with peripheral and <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span> is directly proportional to the electrolyte concentration.</p>
<p>Solutions containing potassium ions should be used with great care, if at all, in patients with <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>, severe <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal failure</span>, and in conditions in which potassium retention is present. </p>
<p>In patients with diminished renal function, administration of solutions containing potassium ions may result in potassium retention.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_e74c2ca6-9a33-43e7-9997-1d2ade4e4ed4"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="LINK_d3960ad6-800b-484f-bc4e-ee1d8564b60e"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">These solutions should be used with care in patients with <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span>, <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>, <span class="product-label-link" type="condition" conceptid="194406" conceptname="Urinary tract obstruction">urinary tract obstruction</span>, or impending or frank cardiac decompensation.</p>
<p>Extraordinary electrolyte losses such as may occur during protracted nasogastric suction, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> or <span class="product-label-link" type="condition" conceptid="4295370" conceptname="Gastrointestinal fistula">gastrointestinal fistula</span> drainage may necessitate additional electrolyte supplementation. </p>
<p>Additional essential electrolytes, minerals, and vitamins should be supplied as needed.</p>
<p>Care should be exercised in administering solutions containing potassium to patients with renal or cardiovascular insufficiency, with or without <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, particularly if they are postoperative or elderly.</p>
<p><span class="Bold">Potassium therapy should be guided primarily by serial electrocardiograms, especially in patients receiving digitalis. Serum potassium levels are not necessarily indicative of tissue potassium levels.</span></p>
<p>Solutions containing potassium should be used with caution in the presence of cardiac disease, particularly when accompanied by <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>.</p>
<p>Solutions containing dextrose should be used with caution in patients with overt or known <span class="product-label-link" type="condition" conceptid="44808385" conceptname="Pre-diabetes">subclinical diabetes</span> mellitus, or carbohydrate intolerance for any reason. </p>
<p>To minimize the risk of possible incompatibilities arising from mixing any of these solutions with other additives that may be prescribed, the final infusate should be inspected for cloudiness or precipitation immediately after mixing, prior to administration, and periodically during administration.</p>
<p>Do not use plastic container in series connection.</p>
<p>If administration is controlled by a pumping device, care must be taken to discontinue pumping action before the container runs dry or <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span> may result. If administration is not controlled by a pumping device, refrain from applying excessive pressure (&gt;300mmHg) causing distortion to the container such as wringing or twisting. Such handling could result in breakage of the container.</p>
<p>These solutions are intended for intravenous administration using sterile equipment. It is recommended that intravenous administration apparatus be replaced at least once every 24 hours.</p>
<p>Use only if solution is clear and container and seals are intact.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="LINK_e7ec0859-f098-44f1-94b7-9891c5a1da2b"></a><a name="section-6.2"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Significant deviations from normal concentrations may require tailoring of the electrolyte pattern, in these or alternative solutions. </p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="LINK_3e88bfbb-131c-4c2d-9a3d-fa10b76f17bf"></a><a name="section-6.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Studies with Potassium Chloride in 5% Dextrose Injections USP have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="LINK_918ced11-14fc-4411-8aea-e0a958751beb"></a><a name="section-6.4"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="LINK_5e8093de-055a-46d1-b1a8-a6bb41a1782a"></a><a name="section-6.4.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<p class="First">Pregnancy Category C. Animal reproduction studies have not been conducted with Potassium Chloride in 5% Dextrose Injections USP. It is also not known whether Potassium Chloride in 5% Dextrose Injections USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Potassium Chloride in 5% Dextrose Injections USP should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34079-4">
<a name="LINK_21e45e27-37e9-4b6c-8edf-735642ec1c30"></a><a name="section-6.5"></a><p></p>
<h2>Labor and Delivery</h2>
<p class="First">The effects of Potassium Chloride in Dextrose Injections USP on the duration of labor or delivery, on the possibility that forceps delivery or other intervention or resuscitation of the newborn will be necessary, and on the later growth, development, and functional maturation of the child are unknown.</p>
<p>As reported in the literature, potassium containing solutions have been administered during labor and delivery. Caution should be exercised, and the fluid balance, glucose and electrolyte concentrations, and acid-base balance, of both mother and fetus should be evaluated periodically or whenever warranted by the condition of the patient or fetus.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="LINK_52a61827-413d-41b4-91f9-cb6730acd969"></a><a name="section-6.6"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether these drugs are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Potassium Chloride in 5% Dextrose Injections USP are administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="LINK_350d5fa9-362f-4406-99e3-1f059a462369"></a><a name="section-6.7"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness of Potassium Chloride in Dextrose Injections USP in pediatric patients have not been established by adequate and well-controlled studies. However, as referenced in the medical literature, potassium chloride injection has been used to treat pediatric patients with <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">potassium deficiency</span> when oral replacement therapy is not feasible.</p>
<p>For patients receiving potassium supplement at greater than maintenance rates, frequent monitoring of serum potassium levels and serial EKGs are recommended. </p>
<p>Dextrose is safe and effective for the stated indications in pediatric patients (see<span class="Bold"><a href="#LINK_9661bd9f-458c-42d0-994f-c78f01aea5b2">INDICATIONS AND USAGE</a></span>). As reported in the literature, the dosage selection and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span>/<span class="product-label-link" type="condition" conceptid="24609" conceptname="Hypoglycemia">hypoglycemia</span>. Frequent monitoring of serum glucose concentrations is required when dextrose is prescribed to pediatric patients, particularly neonates and low birth weight infants.</p>
<p>In neonates or in very small infants even small volumes of fluid may affect fluid and electrolyte balance. Care must be exercised in treatment of neonates, especially pre-term neonates, whose renal function may be immature and whose ability to excrete fluid and solute loads may be limited. Fluid intake, urine output, and serum electrolytes should be monitored closely.</p>
<p>See <span class="Bold"><a href="#LINK_65a68f50-87eb-4ba1-91b3-1c6ef7c2a01e">WARNINGS</a></span> and <span class="Bold"><a href="#LINK_426d082d-837c-4c43-a621-b3213606254d">DOSAGE AND ADMINISTRATION</a></span>.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="LINK_0f8f02a8-f42a-4820-bd10-809c59ce1579"></a><a name="section-6.8"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of Potassium Chloride in Dextrose Injections USP did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients.</p>
<p>In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p>
<p>These drugs are known to be substantially excreted by the kidney, and the risk of toxic reactions to these drugs may be greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p>
<p>See <span class="Bold"><a href="#LINK_65a68f50-87eb-4ba1-91b3-1c6ef7c2a01e">WARNINGS</a></span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="LINK_db482e8d-5e7c-49bf-91e2-15f7526204f6"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Reactions which may occur because of the solution or the technique of administration include febrile response, <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> at the site of injection, <span class="product-label-link" type="condition" conceptid="444247" conceptname="Venous thrombosis">venous thrombosis</span> or <span class="product-label-link" type="condition" conceptid="318174" conceptname="Phlebitis">phlebitis</span> extending from the site of injection, <span class="product-label-link" type="condition" conceptid="4295895" conceptname="Extravasation">extravasation</span> and <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span>.</p>
<p>Symptoms may result from an excess or deficit of one or more of the ions present in the solution; therefore, frequent monitoring of electrolyte levels is essential.</p>
<p>Reactions reported with the use of potassium-containing solutions include <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span> and <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>. The signs and symptoms of potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> include <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span> of the extremities, <span class="product-label-link" type="condition" conceptid="4290597" conceptname="Absent reflex">areflexia</span>, muscular or <span class="product-label-link" type="condition" conceptid="4275136" conceptname="Paralysis of diaphragm">respiratory paralysis</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="316135" conceptname="Atrioventricular block">heart block</span>, electrocardiographic abnormalities and <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>. Potassium deficits result in disruption of neuromuscular function, and intestinal <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span> and dilatation. </p>
<p>If infused in large amounts, chloride ions may cause a loss of <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> ions, resulting in an acidifying effect.</p>
<p>Dextrose may be administered at a rate of 0.5 g/kg/hour without producing <span class="product-label-link" type="condition" conceptid="434164" conceptname="Glycosuria">glycosuria</span>. <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">Hyperglycemia</span> and <span class="product-label-link" type="condition" conceptid="434164" conceptname="Glycosuria">glycosuria</span> may be a function of rate of administration or metabolic insufficiency. Appropriate therapy may include slowing of the infusion rate and administration of insulin.</p>
<p>The physician should also be alert to the possibility of adverse reactions to drug additives. Prescribing information for drug additives to be administered in this manner should be consulted.</p>
<p>If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="LINK_f35a14a4-f092-406a-98fd-1f8de72f7043"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">In the event of a fluid or solute overload during parenteral therapy, reevaluate the patient's condition and institute appropriate corrective treatment.</p>
<p>In the event of overdosage with potassium-containing solutions, discontinue the infusion immediately and institute corrective therapy to reduce serum potassium levels.</p>
<p>Treatment of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> includes the following:</p>
<ol class="Arabic">
<li>Dextrose Injection USP, 10% or 25% containing 10 units of crystalline insulin per 20 grams of dextrose administered intravenously, 300 to 500 mL per hour. 
</li>
<li>Absorption and exchange of potassium using sodium or ammonium cycle cation exchange resin, orally and as retention enema. 
</li>
<li>Hemodialysis and peritoneal dialysis. The use of potassium-containing foods or medications must be eliminated. However, in cases of digitalization, too rapid a lowering of plasma potassium concentration can cause <span class="product-label-link" type="condition" conceptid="433667" conceptname="Poisoning by tetanus vaccine">digitalis toxicity</span>.</li>
</ol>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="LINK_426d082d-837c-4c43-a621-b3213606254d"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">These solutions are for intravenous use only.</p>
<p>Dosage is to be directed by a physician and is dependent upon age, weight, clinical condition of the patient and laboratory determinations. Frequent laboratory determinations and clinical evaluation are essential to monitor changes in blood glucose and electrolyte concentrations, and fluid and electrolyte balance during prolonged parenteral therapy.</p>
<p>Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient.</p>
<p>If the serum potassium level is greater than 2.5 mEq/liter, potassium chloride should be given at a rate not to exceed 10 mEq/hour in a concentration less than 30 mEq/liter. The total 24-hour dose should not exceed 200 mEq.</p>
<p>If urgent treatment is indicated (serum potassium level less than 2.0 mEq/liter with electrocardiographic changes or <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span>), potassium chloride may be infused at a rate of 40 mEq/hour. As much as 400 mEq may be administered in a 24-hour period while monitoring blood electrolyte concentrations carefully.</p>
<p>Dextrose may be administered to normal individuals at a rate of 0.5 g/kg/hour without producing <span class="product-label-link" type="condition" conceptid="434164" conceptname="Glycosuria">glycosuria</span>. At the maximum infusion rate of 0.8 g/kg/hour, approximately 95% of the dextrose is retained.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_c312a622-7e29-46a5-81de-38c52f9c2bee"></a><a name="section-9.1"></a><p></p>
<h2>Pediatric Dosage and Administration</h2>
<p class="First">There is no specific pediatric dose. The dose is dependent on weight, clinical condition and laboratory results. See <span class="Bold"><a href="#LINK_65a68f50-87eb-4ba1-91b3-1c6ef7c2a01e">WARNINGS</a></span> and <span class="Bold"><a href="#LINK_e74c2ca6-9a33-43e7-9997-1d2ade4e4ed4">PRECAUTIONS</a></span>.</p>
<p>Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_cdfeb8ff-9ae9-4d62-a10a-032e2aa48049"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Potassium Chloride in 5% Dextrose Injections USP are supplied sterile and nonpyrogenic in 1000 mL EXCEL<span class="Sup">®</span> Containers packaged 12 per case.</p>
<table>
<col>
<col>
<col>
<thead><tr class="First Last">
<th align="center" valign="bottom">NDC</th>
<th valign="bottom">Cat. No.</th>
<th valign="bottom">Size</th>
</tr></thead>
<tbody>
<tr class="First">
<td colspan="2" valign="bottom"> 0.15% Potassium Chloride in 5% Dextrose Injection USP (20 mEq K<span class="Sup">+</span>/liter)<br>(Canada DIN 01931539)</td>
<td valign="bottom"> </td>
</tr>
<tr>
<td align="center" valign="bottom"> 0264-7625-00</td>
<td valign="bottom"> L6250</td>
<td valign="bottom"> 1000 mL</td>
</tr>
<tr>
<td colspan="2" valign="bottom"> 0.30% Potassium Chloride in 5% Dextrose Injection USP (40 mEq K<span class="Sup">+</span>/liter)<br>(Canada DIN 01967770)</td>
<td valign="bottom"> </td>
</tr>
<tr class="Last">
<td align="center" valign="bottom"> 0264-7628-00</td>
<td valign="bottom"> L6280</td>
<td valign="bottom"> 1000 mL</td>
</tr>
</tbody>
</table>
<div class="Section" data-sectionCode="44425-7">
<a name="LINK_b9afb390-7563-4e89-845d-4da1deb84fad"></a><a name="section-10.1"></a><p></p>
<h2></h2>
<p class="First">Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product.</p>
<p>Storage in automated dispensing machines: Brief exposure up to 2 weeks to ultraviolet or fluorescent li­­­­ght does not adversely affect the product labeling legibility; prolonged exposure can cause fading of the red label. Rotate stock frequently.</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_615d9880-74e3-48ad-8480-e51a373fc902"></a><a name="section-11"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx only</span><br>Revised: September 2010<br>EXCEL is a registered trademark of B. Braun Medical Inc.</p>
</div>
<div class="Section" data-sectionCode="42230-3">
<a name="LINK_32a9858e-9588-4644-a2ab-514f64d5f65f"></a><a name="section-12"></a><p></p>
<h1>Directions for Use of EXCEL<span class="Sup">®</span> Container</h1>
<p class="First"><span class="Bold">Caution:</span> Do not use plastic container in series connection.</p>
<p><span class="Bold">To Open</span></p>
<p>Tear overwrap down at notch and remove solution container. Check for minute leaks by squeezing solution container firmly. If leaks are found, discard solution as <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired. If supplemental medication is desired, follow directions below before preparing for administration. </p>
<p><span class="Bold">Note:</span> Before use, perform the following checks:</p>
<ul class="Disk">
<li> Inspect each container. Read the label. Ensure solution is the one ordered and is within the expiration date.
</li>
<li> Invert container and carefully inspect the solution in good light for cloudiness, haze, or particulate matter. Any container which is suspect should not be used. 
</li>
<li> Use only if solution is clear and container and seals are intact.</li>
</ul>
<p><span class="Bold">Preparation for Administration</span></p>
<ol class="Arabic">
<li>Remove plastic protector from sterile set port at bottom of container. 
</li>
<li>Attach administration set. Refer to complete directions accompanying set. </li>
</ol>
<p><span class="Bold">To Add Medication</span></p>
<p><span class="Bold">Warning:</span> Some additives may be incompatible.</p>
<p><span class="Bold">To Add Medication Before Solution Administration</span></p>
<ol class="Arabic">
<li>Prepare medication site.
</li>
<li>Using syringe with 18–22 gauge needle, puncture medication port and inner diaphragm and inject.
</li>
<li>Squeeze and tap ports while ports are upright and mix solution and medication thoroughly.</li>
</ol>
<p><span class="Bold">To Add Medication During Solution Administration</span></p>
<ol class="Arabic">
<li>Close clamp on the set.
</li>
<li>Prepare medication site.
</li>
<li>Using syringe with 18–22 gauge needle of appropriate length (at least 5/8 inch), puncture resealable medication port and inner diaphragm and inject.
</li>
<li>Remove container from IV pole and/or turn to an upright position.
</li>
<li>Evacuate both ports by tapping and squeezing them while container is in the upright position.
</li>
<li>Mix solution and medication thoroughly.
</li>
<li>Return container to in use position and continue administration.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_80008b5a-16d1-4914-bd8b-cc89d2a66c6e"></a><a name="section-13"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">B. Braun Medical Inc.</span><br>Irvine, CA 92614-5895 USA<br>Made in USA</p>
<p>In Canada, distributed by:<br><span class="Bold">B. Braun Medical Inc.<br></span>Scarborough, Ontario M1H 2W4</p>
<p>Y36-002-758     LD-235-1</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_2d06d6cd-afb1-4b29-bde0-31bcfc9a42a4"></a><a name="section-14"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 1000 mL Container Label</h1>
<p class="First"><span class="Bold">0.15% Potassium Chloride in <br>5% Dextrose Injection USP</span></p>
<p><span class="Bold">REF L6250<br>NDC 0264-7625-00<br>DIN 01931539</span></p>
<p><span class="Bold">1000 mL</span><br><span class="Italics">EXCEL</span><span class="Sup">® </span><span class="Italics">CONTAINER</span></p>
<p><span class="Italics">20 mEq K<span class="Sup">+</span>/liter<br></span>Y94-003-096   LD-265-1</p>
<p><span class="Bold">Each 100 mL contains: <br>Hydrous Dextrose USP 5 g<br>Potassium Chloride USP 0.15 g <br>Water for Injection USP qs</span></p>
<p><span class="Bold">pH: 4.3 (3.5-6.5) <br>Calc. Osmolarity: 295 mOsmol/liter</span></p>
<p><span class="Bold">Electrolytes (mEq/liter):     K<span class="Sup">+ </span>20     Cl<span class="Sup">– </span>20</span></p>
<p>Sterile, nonpyrogenic. Single dose container.</p>
<p>Do not use in series connection. <br>For intravenous use only. Use only if solution is clear and container and seals are intact.</p>
<p><span class="Bold">WARNINGS:</span> Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</p>
<p>Recommended Storage: <br>Room temperature (25°C). Avoid excessive heat. <br>Protect from freezing. See Package Insert.</p>
<p><img alt="Latex free, DEHP free, PVC free" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&amp;name=potassium-chloride-in-dextrose-in-excel-2.jpg"><p class="MultiMediaCaptionNotCentered"></p><br>Rx only<br><img alt="Recycle 7" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&amp;name=potassium-chloride-in-dextrose-in-excel-3.jpg"><p class="MultiMediaCaptionNotCentered"></p><br>EXCEL is a registered trademark of B. Braun Medical Inc.</p>
<p><span class="Bold">B. Braun Medical Inc.</span><br>Irvine, CA 92614-5895 USA<br>1-800-227-2862<br><a href="#www.bbraun.com">www.bbraun.com</a><br>Made in USA</p>
<p>In Canada, distributed by:<br><span class="Bold">B. Braun Medical Inc.<br></span>Scarborough, Ontario M1H 2W4</p>
<p>Y94-003-062<br>LD-168-1</p>
<p>Do not remove overwrap until ready for use. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard solution as <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired.</p>
<p>EXP <br>LOT</p>
<div class="Figure">
<img alt="Container Label L6250" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&amp;name=potassium-chloride-in-dextrose-in-excel-4.jpg"><p class="MultiMediaCaption"></p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_a3f42fda-a73c-4808-a471-cf0db52002d6"></a><a name="section-15"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 1000 mL Container Label</h1>
<p class="First"><span class="Bold">0.30% Potassium Chloride in <br>5% Dextrose Injection USP</span></p>
<p><span class="Bold">REF L6280<br>NDC 0264-7628-00<br>DIN 01967770</span></p>
<p><span class="Bold">1000 mL</span><br><span class="Italics">EXCEL</span><span class="Sup">® </span><span class="Italics">CONTAINER</span></p>
<p><span class="Italics">40 mEq K<span class="Sup">+</span>/liter<br></span>Y94-003-095   LD-264-1</p>
<p><span class="Bold">Each 100 mL contains: <br>Hydrous Dextrose USP 5 g<br>Potassium Chloride USP 0.3 g <br>Water for Injection USP qs</span></p>
<p><span class="Bold">pH: 4.3 (3.5-6.5) <br>Calc. Osmolarity: 330 mOsmol/liter</span></p>
<p><span class="Bold">Electrolytes (mEq/liter):     K<span class="Sup">+ </span>40     Cl<span class="Sup">– </span>40</span></p>
<p>Sterile, nonpyrogenic. Single dose container.</p>
<p>Do not use in series connection. <br>For intravenous use only. Use only if solution is clear and container and seals are intact.</p>
<p><span class="Bold">WARNINGS:</span> Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</p>
<p>Recommended Storage: <br>Room temperature (25°C). Avoid excessive heat. <br>Protect from freezing. See Package Insert.</p>
<p><img alt="Latex free, DEHP free, PVC free" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&amp;name=potassium-chloride-in-dextrose-in-excel-5.jpg"><br>Rx only<br><img alt="Recycle 7" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&amp;name=potassium-chloride-in-dextrose-in-excel-6.jpg"><br>EXCEL is a registered trademark of B. Braun Medical Inc.</p>
<p><span class="Bold">B. Braun Medical Inc.</span><br>Irvine, CA 92614-5895 USA<br>1-800-227-2862<br>www.bbraun.com<br>Made in USA</p>
<p>In Canada, distributed by:<br><span class="Bold">B. Braun Medical Inc.<br></span>Scarborough, Ontario M1H 2W4</p>
<p>Y94-003-063<br>LD-167-2</p>
<p>Do not remove overwrap until ready for use. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard solution as <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired.</p>
<p>EXP <br>LOT</p>
<div class="Figure">
<img alt="Container Label L6280" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&amp;name=potassium-chloride-in-dextrose-in-excel-7.jpg"><p class="MultiMediaCaption"></p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POTASSIUM CHLORIDE IN DEXTROSE 		
					</strong><br><span class="contentTableReg">dextrose and potassium chloride solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0264-7625</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DEXTROSE</strong> (DEXTROSE) </td>
<td class="formItem">DEXTROSE</td>
<td class="formItem">5 g  in 100 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POTASSIUM CHLORIDE</strong> (POTASSIUM CATION) </td>
<td class="formItem">POTASSIUM CHLORIDE</td>
<td class="formItem">0.15 g  in 100 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0264-7625-00</td>
<td class="formItem">12  in 1 CASE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1000 mL in 1 CONTAINER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019699</td>
<td class="formItem">09/29/1989</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POTASSIUM CHLORIDE IN DEXTROSE 		
					</strong><br><span class="contentTableReg">dextrose and potassium chloride solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0264-7628</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DEXTROSE</strong> (DEXTROSE) </td>
<td class="formItem">DEXTROSE</td>
<td class="formItem">5 g  in 100 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POTASSIUM CHLORIDE</strong> (POTASSIUM CATION) </td>
<td class="formItem">POTASSIUM CHLORIDE</td>
<td class="formItem">0.3 g  in 100 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0264-7628-00</td>
<td class="formItem">12  in 1 CASE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1000 mL in 1 CONTAINER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019699</td>
<td class="formItem">09/29/1989</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>B. Braun Medical Inc.
							(002397347)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 7/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>469ce3e3-9cde-406f-a967-00e9744d12db</div>
<div>Set id: e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23</div>
<div>Version: 8</div>
<div>Effective Time: 20110711</div>
</div>
</div> <div class="DistributorName">B. Braun Medical Inc.</div></p>
</body></html>
